BOSTON SCIENTIFIC CORP (BSX) revenue & profit
BOSTON SCIENTIFIC CORP (BSX): revenue $20.1B, net income – in 2025; latest quarter +7.5% year over year. From SEC filings.
$20.1BRevenue 2025
TickerBSX (NYSE)
IndustryHealthcare · Surgical & Medical Instruments & Apparatus
Revenue 2025$20.1B
Net income 2025–
Net margin–
Annual revenue growth+19.9%
Latest quarter (2026 Q2) · Revenue$5.4B
vs. same quarter last year+7.5%
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $12.7B | – | |
| 2023 | $14.2B | – | |
| 2024 | $16.7B | – | |
| 2025 | $20.1B | – |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.